MMIRF (MedMira) ROIC %: -9.34% (As of Jan. 2026)


What is MedMira ROIC %?

MedMira MMIRF +302.48% ROIC % is -9.34% as of Jan. 2026. The stock has 6 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. MedMira's annualized return on invested capital (ROIC %) for the quarter that ended in Jan. 2026 was -9.34%.

As of today (2026-06-27), MedMira's WACC % is 10.76%. MedMira's ROIC % is -14.94% (calculated using TTM income statement data). MedMira earns returns that do not match up to its cost of capital. It will destroy value as it grows.


MedMira  (OTCPK:MMIRF) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, MedMira's WACC % is 10.76%. MedMira's ROIC % is -14.94% (calculated using TTM income statement data). MedMira earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


MedMira ROIC % Related Terms


MedMira ROIC % Historical Data

* Premium members only.

The historical data trend for MedMira's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMira ROIC % Chart

MedMira Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 -11.02 -18.05 -18.84 -22.36

MedMira Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.86 -19.00 -18.51 -14.36 -9.34

MMIRF vs VRTX, REGN, ALNY: ROIC % Comparison

For the Biotechnology subindustry, MedMira's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMira ROIC % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's ROIC % distribution charts can be found below:

* The bar in red indicates where MedMira's ROIC % falls into.



MedMira ROIC % Calculation

MedMira's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Jul. 2025 is calculated as:

ROIC % (A: Jul. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Jul. 2024 ) + Invested Capital (A: Jul. 2025 ))/ count )
=-2.519 * ( 1 - 0% )/( (11.327 + 11.208)/ 2 )
=-2.519/11.2675
=-22.36 %

where

MedMira's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Jan. 2026 is calculated as:

ROIC % (Q: Jan. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2025 ) + Invested Capital (Q: Jan. 2026 ))/ count )
=-1.176 * ( 1 - 0% )/( (12.417 + 12.759)/ 2 )
=-1.176/12.588
=-9.34 %

where

Note: The Operating Income data used here is four times the quarterly (Jan. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of -9.34% mean?
MedMira (MMIRF) has a ROIC % of -9.34% as of Jan. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on MedMira and its competitors.
Is MedMira's ROIC % too high?
MedMira's current ROIC % is -9.34%.
How does MedMira's ROIC % compare to VRTX and REGN?
MedMira's ROIC % of -9.34% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Biotechnology company?
A good ROIC % depends on the Biotechnology industry context. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on MedMira and its competitors. MedMira's current ROIC % is -9.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMira stock overvalued right now?
MedMira (MMIRF) has a current ROIC % of -9.34%. The current ROIC % is -9.34%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For MedMira (MMIRF), the current ROIC % is -9.34% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMira Business Description

Other Exchanges MIR:Canada
Address 155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.